Back to search
FDAFDA · Food and drugs·Recall number D-1183-2018

Ethosuximide Capsules, USP, 250 mg, 100 capsules per bottle, Rx only, Mfg For VersaPharm Incorporated, Maroerre, GA 30062. Mfg By: Swiss Caps AG, Kirchberg, Switzerland. NDC: 61748-025-01

Published September 12, 2018 · Recall initiated: August 24, 2018

Summary

FDA records drug Class II recall D-1183-2018, published September 12, 2018 and initiated August 24, 2018. Recalling firm: Akorn, Inc.; Status: Terminated; Reported quantity: 23,788 100-count bottles; Lot: Lots: 1165280100, 1165280101, EXP 3/2019. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications: Out of specification (OOS) results for unspecified impurity.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Akorn, Inc.
Distributor
Nationwide in the USA
Lot
Lots: 1165280100, 1165280101, EXP 3/2019
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Ethosuximide Capsules, USP, 250 mg, 100 capsules per bottle, Rx only, Mfg For VersaPharm Incorporated, Maroerre, GA 30062. Mfg By: Swiss Caps AG, Kirchberg, Switzerland. NDC: 61748-025-01 recalled?

Yes. FDA published recall D-1183-2018 on September 12, 2018. Reported hazard: Failed Impurities/Degradation Specifications: Out of specification (OOS) results for unspecified impurity.

What should I do if I have this product?

Voluntary: Firm initiated · Letter